POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS Russian patent published in 2020 - IPC A61K38/02 A61K35/30 A61P25/00 

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine and concerns a composition of polypeptides prepared from cerebrum brain extract possessing nootropic, neuroptrotector, antioxidant and tissue-specific action, characterized by the following values: molecular weight of polypeptides is approximately 2000–2250 Da; amount of bound amino acids makes arginine 5 to 37 mcg/mg of dry residue of composition, glycine - from 11 to 21 mcg/mg, asparagine - from 37 to 97 mcg/mg and glutamine - from 41 to 101 mcg/mg of dry residue of composition. Group of inventions also relates to a pharmaceutical composition containing said composition of polypeptides and a pharmaceutically acceptable carrier; using said composition of polypeptides as a neuroprotective agent.

EFFECT: group of inventions provides nootropic, neuroptrotector, antioxidant and tissue-specific action.

12 cl, 6 dwg, 9 ex